StocksAtara Biotherapeutics IncATRA

ATRA

Atara Biotherapeutics Inc

15.10 -0.1036 (-0.68%)
Delayed Prices By NASDAQ, in USD Market Open
Trade
S
15.10
B
15.14

Overview

Prev Close15.20
Day's Range14.99 - 15.27
52 Week Range11.79 - 28.20
Average Volume (3m)769.12K
1-Year Return6.70%
Beta1.4406
Market Cap1.29B
P/E Ratio
Revenue7.42M
EPS-3.6349
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.714/05/202127/07/202107/10/202112.000013.000014.000015.000016.000017.000018.0000
Chart times in UTC
Industry Biotechnology
CEO Pascal Touchon, DVM, MBA
Employees 437

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2020: Atara Biotherapeutics Inc's revenues decreased by NaN and amounted to 0.00. Net income decreased by 5.38% to -306.62M. Net assets increased by 59.00% to 462.34M and EPS increased from -5.67 to -4.15.
ATRA's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
N/A
Net Profit Margin
N/A
Operating Margin
-4,298.34%
Return On Investment
-65.24%
09/20
12/20
03/21
06/21
Total Revenue
0
0
3.55M
3.87M
Gross Profit
-2.57M
-2.53M
N/A
N/A
Operating Income
-74.71M
-81.7M
-78.62M
-84M
Net Income
-74.35M
-81.31M
-78.34M
-83.79M